Copenhagen, Denmark

Vladimir Berezin

This inventor holds 19 USPTO granted patents and 5 published patent applications and 1 EPO patent, primarily in Peptide Therapeutics. Top assignees: University of Copenhagen, University of Tasmania, Enkam Pharmaceuticals A/s. Active years: 2005-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vladimir Berezin. Retrieved from https://idiyas.com/inventor/vladimir-berezin-a0lmjow9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 31.6


Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 38(Granted Patents)


Location History:

  • Copenhagen N, UA (2008)
  • København N, DK (2011)
  • Kobenhavn N, DK (2012)
  • Copenhagen, DK (2005 - 2018)

Company Filing History:


Years Active: 2005-2018

Loading Chart...
Loading Chart...
Areas of Expertise:
Metallothionein Peptides
Neuropeptide Y
Interleukin-1 Receptor
Neuritogenic Peptides
Fibroblast Growth Factor
NCAM Binding
GDNF Derived Peptides
Neurotrophin Peptides
Cell Survival
Autoimmune Diseases
Synaptic Plasticity
Chronic Inflammation
19 patents (USPTO):Explore Patents

Title: Vladimir Berezin: Innovator in Neurobiology and Peptide Research

Introduction

Vladimir Berezin, based in Copenhagen, Denmark, is an accomplished inventor in the field of neurobiology, holding an impressive portfolio of 19 patents. His work primarily focuses on developing peptide fragments that promote neural cell survival and differentiation, making significant strides in the treatment of various neurological conditions.

Latest Patents

Among his notable patents are:

1. **Metallothionein-derived peptide fragments** - This invention relates to neural cell survival, differentiation, and proliferation-promoting peptide fragments derived from metallothioneins (MT). It includes pharmaceutical compositions comprising these peptide fragments and their applications for treating diseases and conditions where stimulating neural cell proliferation, differentiation, and survival is beneficial, particularly in relation to learning and memory.

2. **Neuropeptide Y-derived peptides** - This patent discloses peptide fragments derived from neuropeptide Y (NPY) that have the capability to selectively bind to the neural cell adhesion molecule (NCAM). These fragments induce neuroplastic and neuroprotective effects, presenting potential uses as neuritogenic agents for treating pathological conditions that require neuroprotection and neuroplastic changes, such as brain and retina disorders.

Career Highlights

Vladimir Berezin has contributed to the scientific community through various channels, including his association with the University of Tasmania. His work has underscored the importance of peptide research in neurobiology, bridging gaps between basic scientific discoveries and clinical applications.

Collaborations

Throughout his career, Berezin has collaborated with notable researchers such as Elisabeth Bock and Milena Penkowa. These collaborations have likely facilitated cross-disciplinary innovations and enhanced the breadth of his research endeavors.

Conclusion

Vladimir Berezin's contributions to the field of neurobiology and peptide research exemplify the potential of innovation in addressing complex medical challenges. His extensive patent portfolio and collaborative efforts reflect a commitment to advancing our understanding of neural functions and developing therapeutic solutions for neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…